Abstract
Submaximal dose pentagastrin tests conducted in normal male volunteers with L‐643.441, a novel histamine H2‐receptor antagonist, indicate that it is a potent and long‐acting inhibitor of gastric acid secretion. The effect appears dose‐dependent and single doses of 50 mg are sufficient to reduce secretory potential by at least 50% when examined 24 h after drug administration. No adverse effects attributable to treatment were observed. 1985 The British Pharmacological Society
Original language | English |
---|---|
Pages (from-to) | 133-136 |
Number of pages | 4 |
Journal | British Journal of Clinical Pharmacology |
Volume | 20 |
Issue number | 2 |
DOIs | |
Publication status | Published - Aug 1985 |
Externally published | Yes |